Document is current
Any future updates will be listed below
-
Authors
Verkissen, Mariëtte N. http://orcid.org/0000-0002-7797-5290
De Vleminck, Aline
Groenvold, Mogens
Jabbarian, Lea J.
Bulli, Francesco
Cools, Wilfried
van Delden, Johannes J. M.
Lunder, Urška
Miccinesi, Guido
Payne, Sheila A.
Pollock, Kristian
Rietjens, Judith A. C.
Deliens, Luc
-
Funding
Funding for this research was provided by:
European Union's Seventh Framework Programme for Research and Technological Development (6025410-2)
- License Information
-
More Information
Article History
Received: 22 December 2020
Accepted: 11 March 2021
First Online: 19 March 2021
Declarations
:
: The ACTION trial was registered in the International Standard Randomised Controlled Trial Number (ISRCTN) registry (ISRCTN63110516) as of March 10, 2014. Ethical committee procedures were followed and approval was obtained in all countries and institutions involved.
: Patients who were deemed eligible by their care team and willing to consider possible participation were provided with more information about the study by the research team. Patients were given unrestricted time to consider participation and were informed that they were free to withdraw from participating in the study without any effect on their care. Prior to study enrollment, each participant in this study gave written informed consent to take part in the research.
: All study participants agreed to the use of their (anonymized) data as outlined in the information given to them prior to the study start.
: The authors declare no competing interests.
